Patel AM et al. |
Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. |
2013 |
Ann. Intern. Med. |
pmid:23778904
|
Steinman MA et al. |
Changing use of antibiotics in community-based outpatient practice, 1991-1999. |
2003 |
Ann. Intern. Med. |
pmid:12667022
|
Chaisson RE et al. |
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. |
1994 |
Ann. Intern. Med. |
pmid:7978715
|
Goldberger M and Masur H |
Clarithromycin therapy for Mycobacterium avium complex disease in patients with AIDS: potential and problems. |
1994 |
Ann. Intern. Med. |
pmid:7978725
|
Neu HC |
New macrolide antibiotics: azithromycin and clarithromycin. |
1992 |
Ann. Intern. Med. |
pmid:1310839
|
De Francesco V et al. |
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. |
2006 |
Ann. Intern. Med. |
pmid:16418408
|
Trivedi S et al. |
Clarithromycin and digoxin toxicity. |
1998 |
Ann. Intern. Med. |
pmid:9518419
|
Yang YJ et al. |
Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes. |
2017 |
Ann. Med. |
pmid:28266875
|
Trotti LM et al. |
Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial. |
2015 |
Ann. Neurol. |
pmid:26094838
|
Ferreri AJ et al. |
High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial. |
2015 |
Ann. Oncol. |
pmid:25935794
|
Di Raimondo F et al. |
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma? |
2007 |
Ann. Oncol. |
pmid:17065587
|
Rhee CS et al. |
Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. |
2000 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10823478
|
Heffernan CB et al. |
Does Clarithromycin Cause Hearing Loss? A 12-Year Review of Clarithromycin Therapy for Nontuberculous Mycobacterial Lymphadenitis in Children. |
2018 |
Ann. Otol. Rhinol. Laryngol. |
pmid:30032669
|
Clifford K et al. |
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. |
1999 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10214783
|
Mullin D et al. |
Mycobacterium chelonae infections involving the head and neck. |
2009 |
Ann. Otol. Rhinol. Laryngol. |
pmid:19894399
|
Callaghan R and Allen M |
Mycobacterium malmoense infection of the knee. |
2003 |
Ann. Rheum. Dis. |
pmid:14583565
|
Hiramatsu M et al. |
Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. |
2012 |
Ann. Thorac. Surg. |
pmid:22119119
|
Fan X et al. |
Lung perfusion with clarithromycin ameliorates lung function after cardiopulmonary bypass. |
2006 |
Ann. Thorac. Surg. |
pmid:16488691
|
Nelson KG et al. |
Results of operation in Mycobacterium avium-intracellulare lung disease. |
1998 |
Ann. Thorac. Surg. |
pmid:9725364
|
Kadir IS et al. |
Recurrent acute rheumatic fever: a forgotten diagnosis? |
2004 |
Ann. Thorac. Surg. |
pmid:15276555
|
Bossert T et al. |
Successful management of two heart transplant recipients with mycobacterial pulmonary infections. |
2005 |
Ann. Thorac. Surg. |
pmid:16039241
|
Watanabe M et al. |
Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones. |
2006 |
Ann. Thorac. Surg. |
pmid:16731124
|
Gintovt EA |
[Use of clarithromycin in the treatment of atopic dermatitis complicated by staphylococcal infection]. |
2004 |
Antibiot. Khimioter. |
pmid:15164520
|
Vasil'ev IuV and Zvenigorodskaia LA |
[Fromilide (clarithromycin) in eradication of Helicobacter pylori in patients with duodenal ulcer]. |
2002 |
Antibiot. Khimioter. |
pmid:12365323
|
Iakovlev EA et al. |
[Present stage of chemotherapy and chemoprophylaxis of rickettsiosis and Q fever]. |
2011 |
Antibiot. Khimioter. |
pmid:22856156
|
Iakovlev VP |
[New semisynthetic macrolides. Clarithromycin--its importance in the current therapy of bacterial infections]. |
1999 |
Antibiot. Khimioter. |
pmid:10635418
|
Evdokimova AG et al. |
[New approaches to therapy of Helicobacterpylori infection (by the materials of the Maastricht Consensus-IV, Florence, 2010)]. |
2013 |
Antibiot. Khimioter. |
pmid:24640139
|
Iakovlev VP et al. |
[Macrolide antibiotic clarithromycin (Klabax) in treatment of community-acquired respiratory tract infections]. |
2000 |
Antibiot. Khimioter. |
pmid:11210297
|
Shcherbakov PL |
[Clarithromycin in eradication therapy of helicobacter infections in children]. |
2001 |
Antibiot. Khimioter. |
pmid:11871315
|
Sazykin IuO et al. |
[Clarithromycin and tumor chemotherapy]. |
2000 |
Antibiot. Khimioter. |
pmid:11210301
|
Iutanova NS |
[Clinical efficacy of clarithromycin delayed release dosage form in the treatment of community-acquired pneumonia]. |
2004 |
Antibiot. Khimioter. |
pmid:15344392
|
Budanov SV and Vasil'ev AN |
[Clarithromycin: specific features of antimicrobial spectrum and clinical use]. |
2004 |
Antibiot. Khimioter. |
pmid:15285409
|
Guchev IA et al. |
[Evaluation of clarithromycin efficacy in the treatment of community-acquired pneumonia on the basis of the Binax NOW test results (a prospective open trial)]. |
2002 |
Antibiot. Khimioter. |
pmid:12619516
|
Aoki D et al. |
Roxithromycin inhibits angiogenesis of human hepatoma cells in vivo by suppressing VEGF production. |
|
Anticancer Res. |
pmid:15816530
|
Ohara T et al. |
Antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice. |
2004 Nov-Dec |
Anticancer Res. |
pmid:15736403
|
Wang G et al. |
Multiplex sequence analysis demonstrates the competitive growth advantage of the A-to-G mutants of clarithromycin-resistant Helicobacter pylori. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10049289
|
Kamoda O et al. |
In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16940102
|
Fong IW et al. |
Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12121899
|
Mor N et al. |
Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7695255
|
Ohtani H et al. |
Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991836
|
Spangler SK et al. |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192445
|
De R et al. |
Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19204190
|
Wolinsky E |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031406
|
Ji B et al. |
Bactericidal and sterilizing activities of several orally administered combined regimens against Mycobacterium ulcerans in mice. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18391038
|
Finch R et al. |
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12019085
|
Barry AL et al. |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840016
|
Nash KA |
Effect of drug concentration on emergence of macrolide resistance in Mycobacterium avium. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11353601
|
Kosowska-Shick K et al. |
Comparative antipneumococcal activities of sulopenem and other drugs. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19307366
|
Lounis N et al. |
Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793860
|
Fattorini L et al. |
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7793873
|